Immunotherapy with interleukin-2 after autologous bone marrow transplantation (ABMT) for acute myelogenous leukemia (AML).

被引：0
|
作者：
Massumoto, CM [1 ]
Macedo, MCA [1 ]
Saboya, R [1 ]
Silva, R [1 ]
Loterio, H [1 ]
Dzik, C [1 ]
Pallotta, R [1 ]
Chamone, DAF [1 ]
Dulley, F [1 ]
机构：
[1] UNIV SAO PAULO,FUNDACAO PRO SANGUE HEMOCENTRO,DEPT HAEMATOL,BR-05508 SAO PAULO,BRAZIL
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4566 / 4566
页数：1
相关论文
共 50 条
  • [1] IMMUNOTHERAPY WITH INTERLEUKIN-2 AFTER ABMT IN AML
    HAMON, MD
    PRENTICE, HG
    GOTTLIEB, DJ
    MACDONALD, ID
    CUNNINGHAM, JM
    SMITH, OP
    GILMORE, M
    GANDHI, L
    COLLIS, C
    BONE MARROW TRANSPLANTATION, 1993, 11 (05) : 399 - 401
  • [2] Interleukin-2 before and/or after autologous bone marrow transplantation for pediatric acute leukemia patients
    Messina, C
    Zambello, R
    Rossetti, F
    Gazzola, MV
    Varotto, S
    Destro, R
    Basso, G
    Semenzato, G
    Zanesco, L
    BONE MARROW TRANSPLANTATION, 1996, 17 (05) : 729 - 735
  • [3] Autologous bone marrow transplant (ABMT) for acute myelogenous leukemia (AML) in second or subsequent remission.
    Califaretti, N
    Davidson, M
    Abraham, R
    Roitman, D
    Crump, M
    Keating, A
    BLOOD, 1998, 92 (10) : 294A - 294A
  • [4] INTERLEUKIN-2 WITH OR WITHOUT LYMPHOKINE-ACTIVATED KILLER-CELLS AS CONSOLIDATIVE IMMUNOTHERAPY AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA
    BENYUNES, MC
    MASSUMOTO, C
    YORK, A
    HIGUCHI, CM
    BUCKNER, CD
    THOMPSON, JA
    PETERSEN, FB
    FEFER, A
    BONE MARROW TRANSPLANTATION, 1993, 12 (02) : 159 - 163
  • [5] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOBLASTIC-LEUKEMIA (AML) IN REMISSION
    MELONI, G
    DEFABRITIIS, P
    PULSONI, A
    SANDRELLI, A
    SIMONE, F
    PETTI, MC
    MANDELLI, F
    INTERNATIONAL JOURNAL OF CELL CLONING, 1985, 3 (04): : 244 - 245
  • [6] BUSULFAN PLUS MELPHALAN (BU/MEL) FOLLOWED BY INTERLEUKIN-2 (IL-2) IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA (AML)
    MASSUMOTO, C
    OSTRONOFF, M
    ZAMBON, E
    ALMEIDA, MC
    BOEHRINGER, B
    CHAMONE, D
    DULLEY, F
    BLOOD, 1994, 84 (10) : A714 - A714
  • [7] Treatment with low dose IL-2 after autologous bone marrow transplantation (ABMT) for acute myeloid leukemia (AML)
    Falkenburg, JHF
    Schaafsma, MR
    Smith, WM
    KluinNelemans, JC
    HooftmandenOtter, A
    Rijnbeek, M
    vandeMarel, A
    Schellekens, M
    Brandely, M
    Fibbe, WE
    Willemze, R
    BLOOD, 1995, 86 (10) : 2252 - 2252
  • [8] Outcome of acute myeloid leukemia (AML) relapsing after autologous bone marrow transplantation (ABMT) in first remission.
    Vignetti, M
    Iacopino, P
    Trasarti, S
    Messina, G
    Barbui, T
    Carella, AM
    Alessandrino, PP
    Benedetti, F
    Falda, M
    Sajeva, MT
    Carlo-Stella, C
    Lambertenghi, G
    Sica, S
    Visani, G
    Meloni, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S4 - S4
  • [9] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) WITH INTERLEUKIN-2 (IL-2) - ACTIVATED BONE-MARROW
    CHARAK, B
    VERMA, U
    CAHILL, R
    MAZUMDER, A
    BLOOD, 1993, 82 (10) : A628 - A628
  • [10] AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) IN ACUTE-LEUKEMIA
    GRIBBEN, JG
    GOLDSTONE, AH
    LINCH, DC
    RICHARDS, JDM
    DONES, L
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 871 - 872
12345